chrishell
Poet laureate of the deep state
- Joined
- Aug 3, 2024
- Posts
- 1,991
- Reputation
- 2,531
DRAFT BILL FOR CONSIDERATION
Appearance‑Equity & Public Enhancement Act of 2025 (AEPEA)
“Leaving no American behind in the natural‑lottery.”
This Act may be cited as the “Appearance‑Equity & Public Enhancement Act of 2025.”
Congress finds that:
To eliminate appearance‑based structural disadvantage by providing universal, publicly financed access to medically supervised aesthetic reconstruction and enhancement.
The Act shall sunset on December 31, 2045 unless re‑authorized. Within 12 months before sunset, HHS shall submit a comprehensive review to Congress detailing economic, health, and social‑equity outcomes.
The AEPEA leverages modern surgical robotics, additive manufacturing, and public‑finance innovation to neutralize a centuries‑old genetic inequity. By treating severe aesthetic disadvantage as a medical and economic impairment—no different than severe myopia or congenital heart defects—the United States will:
Congressional action is hereby requested to enact this transformative equal‑opportunity framework.
Appearance‑Equity & Public Enhancement Act of 2025 (AEPEA)
“Leaving no American behind in the natural‑lottery.”
SECTION 1. SHORT TITLE
This Act may be cited as the “Appearance‑Equity & Public Enhancement Act of 2025.”
SECTION 2. FINDINGS
Congress finds that:
- Empirical research links unattributed facial and skeletal dysmorphia to lower lifetime earnings, higher rates of depression, and reduced civic participation.
- Advanced orthognathic surgery, custom poly‑ether‑ether‑ketone (PEEK) implants, limb‑lengthening, clear aligner therapy, autologous fat grafting, and deep‑plane facelifts are safe, FDA‑approved procedures when performed by qualified clinicians.
- Currently, access to these interventions is limited to the top income decile, entrenching a heritable “beauty premium” inconsistent with equal‑opportunity principles.
SECTION 3. PURPOSE
To eliminate appearance‑based structural disadvantage by providing universal, publicly financed access to medically supervised aesthetic reconstruction and enhancement.
TITLE I — ESTABLISHMENT OF CARE CENTERS
- Centers of Aesthetic Reconstruction & Enhancement (CARE).
- (a) Network Build‑out. One CARE facility shall be established per three million residents, co‑located with Level I trauma hospitals to leverage existing imaging, ICU, and surgical suites.
- (b) Scope of Services. Each CARE shall deliver:
- Bimaxillary (double‑jaw) osteotomies with custom PEEK guides.
- Custom PEEK cranio‑facial and body implants.
- Intramedullary limb‑lengthening using smart nails.
- Clear‑aligner therapy (Invisalign‑class systems).
- Autologous fat grafting.
- Deep‑plane facelifts and adjunct soft‑tissue procedures.
- National Outcomes Registry. All CARE procedures shall be logged in a de‑identified federal database; quarterly complication and satisfaction rates shall be made public.
TITLE II — WORKFORCE ACCELERATION
- Cosmetic & Reconstructive Residency Track. Adds 1,500 funded residency slots annually; graduates must complete five years of service in CARE facilities or repay federal tuition support.
- Technical Upskilling Grants. Five‑year grants to community colleges for training surgical‑robot technicians, biomedical 3‑D–print engineers, and post‑operative tele‑rehab nurses.
TITLE III — COST REDUCTION & TECHNOLOGY DEPLOYMENT
- National PEEK Foundries. The Department of Health and Human Services (HHS) shall operate regional 3‑D print farms producing implants at scale, targeting a 70 % unit‑cost reduction within five years.
- Robotic & AI Surgical Workflow. CARE centers must adopt approved CAD‑CAM planning and robotic execution platforms that decrease average jaw‑surgery OR time by 30 % and limb‑lengthening inpatient stays by 50 %.
- Enhanced Recovery After Surgery (ERAS). Mandated ERAS pathways for all procedures to minimize hospitalization and opioid use.
TITLE IV — FINANCING
- Appearance‑Equity Trust Fund (AETF). A dedicated Treasury account funded by:
- (a) 0.5 % Annual Assessment on Net Household Wealth exceeding $10 million.
- (b) 15 % Reallocation of Department of Defense Discretionary Spending beginning FY 2027.
- (c) Digital Beauty Royalty Levy of 1.5 ¢ per user‑minute on social‑media platforms for content employing algorithmically amplified or synthetic imagery.
- (d) Sovereign Surgical Bonds. Twenty‑year zero‑coupon bonds repaid via a 1 % payroll surcharge on post‑procedure wage gains certified by the IRS.
- Cost Projection.
- Phase‑in (FY 2026‑2030): $2.5 trillion total.
- Full rollout (FY 2031‑2045): $9.8 trillion total.
- Average annual outlay ≈ 11 % of projected GDP, offset by anticipated productivity and wage‑gap gains.
TITLE V — IMPLEMENTATION TIMELINE
| Phase | FY | Coverage Goal | Key Deliverables |
|---|---|---|---|
| Pilot | 2026‑2028 | ≤1 % of pop. with severe psychosocial morbidity | 5 CARE hubs; national registry launch |
| Scale‑Up | 2029‑2032 | 10‑15 % (jaw & aligners) | 40 CARE sites; PEEK foundries online |
| Mass | 2033‑2040 | 50 % clear‑aligner; 25 % jaw & limb | 120 CARE sites; automated monitoring |
| Saturation | 2041‑2045 | 50 % jaw, 75 % other procedures | Outcome parity; wage‑gap <2 % |
TITLE VI — OVERSIGHT AND SAFEGUARDS
- Ethics & Safety Board. Multidisciplinary board under HHS to update procedural safety codes, distraction limits, and implant standards.
- Voluntary Psychological Screening. Offered pre‑operatively; may not be used to deny access absent clear contraindications (e.g., active psychosis).
- Annual GAO Audit. Reports to Congress on cost, outcomes, and equity impact; triggers corrective action if complication rates exceed benchmarks.
TITLE VII — SUNSET & REVIEW
The Act shall sunset on December 31, 2045 unless re‑authorized. Within 12 months before sunset, HHS shall submit a comprehensive review to Congress detailing economic, health, and social‑equity outcomes.
STATEMENT OF IMPACT
The AEPEA leverages modern surgical robotics, additive manufacturing, and public‑finance innovation to neutralize a centuries‑old genetic inequity. By treating severe aesthetic disadvantage as a medical and economic impairment—no different than severe myopia or congenital heart defects—the United States will:
- eliminate the beauty‑wage penalty within two decades;
- reduce appearance‑related depression and anxiety prevalence by an estimated 30 %;
- generate productivity gains projected at $400 billion annually by FY 2045.
Congressional action is hereby requested to enact this transformative equal‑opportunity framework.
